M 
176.60
-2.86%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥32.69bn
FY2021FY2025
Net income
CN¥5.73bn
FY2021FY2025
Free cash flow
CN¥5.35bn
FY2021FY2025
Shareholders' equity
CN¥24.46bn
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | CN¥32.69bn | CN¥21.08bn | CN¥17.24bn | CN¥11.53bn | CN¥10.35bn |
| Gross profit | CN¥10.19bn | CN¥6.84bn | CN¥5.09bn | CN¥3.27bn | CN¥3.24bn |
| Research and development | CN¥101.3m | CN¥89.0m | CN¥72.2m | CN¥27.4m | CN¥17.2m |
| Operating income | CN¥7.14bn | CN¥4.78bn | CN¥3.48bn | CN¥2.20bn | CN¥2.53bn |
| Net income | CN¥5.73bn | CN¥3.77bn | CN¥2.66bn | CN¥1.70bn | CN¥1.91bn |
| Diluted earnings per share | 15.10 | 9.99 | 7.06 | 4.50 | 5.03 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | CN¥30.81bn | CN¥16.80bn | CN¥12.39bn | CN¥8.44bn | CN¥7.32bn |
| Cash and short-term investments | CN¥17.33bn | CN¥7.75bn | CN¥5.42bn | CN¥3.93bn | CN¥3.58bn |
| Total liabilities | CN¥6.03bn | CN¥4.01bn | CN¥3.39bn | CN¥2.09bn | CN¥1.77bn |
| Debt | CN¥187.3m | CN¥78.6m | CN¥327.9m | CN¥239.1m | CN¥142.8m |
| Shareholders' equity | CN¥24.46bn | CN¥12.70bn | CN¥8.92bn | CN¥6.33bn | CN¥5.54bn |
| Shares outstanding | 380m | 377m | 377m | 377m | 380m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | CN¥6.04bn | CN¥5.10bn | CN¥3.22bn | CN¥2.06bn | CN¥1.69bn |
| Capital spending | −CN¥691.5m | −CN¥1.23bn | −CN¥1.44bn | −CN¥1.07bn | −CN¥952.4m |
| Free cash flow | CN¥5.35bn | CN¥3.87bn | CN¥1.79bn | CN¥994.0m | CN¥740.0m |
| Dividends paid | — | — | −CN¥84.9m | −CN¥88.6m | −CN¥404.4m |
Latest quarters
By quarter end
| Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥9.34bn | CN¥9.34bn | CN¥7.44bn | CN¥7.44bn | CN¥5.24bn | CN¥6.78bn | CN¥5.34bn | CN¥5.34bn |
| Gross profit | CN¥2.87bn | CN¥2.87bn | CN¥2.35bn | CN¥2.35bn | CN¥1.71bn | CN¥2.24bn | CN¥1.70bn | CN¥1.70bn |
| Operating income | CN¥1.95bn | CN¥1.95bn | CN¥1.66bn | CN¥1.66bn | CN¥990.0m | CN¥1.73bn | CN¥1.21bn | CN¥1.21bn |
| Net income | CN¥1.60bn | CN¥1.60bn | CN¥1.35bn | CN¥1.35bn | CN¥807.0m | CN¥1.36bn | CN¥942.2m | CN¥942.2m |
| Diluted earnings per share | 4.21 | 4.21 | 3.55 | 3.55 | 2.14 | 3.61 | 2.50 | 2.50 |
| Cash from operations | — | — | CN¥1.64bn | CN¥1.64bn | CN¥770.0m | CN¥1.93bn | CN¥1.42bn | CN¥1.42bn |
| Capital spending | — | — | −CN¥152.0m | −CN¥152.0m | −CN¥211.0m | −CN¥380.0m | −CN¥374.0m | −CN¥374.0m |
| Free cash flow | — | — | CN¥1.49bn | CN¥1.49bn | CN¥559.0m | CN¥1.54bn | CN¥1.04bn | CN¥1.04bn |
| Total assets | CN¥30.79bn | CN¥30.79bn | CN¥27.29bn | CN¥27.29bn | CN¥16.80bn | CN¥15.81bn | — | — |
| Cash and short-term investments | CN¥17.28bn | CN¥17.34bn | CN¥14.87bn | CN¥14.87bn | CN¥7.75bn | CN¥7.76bn | — | CN¥6.41bn |
| Debt | CN¥187.3m | CN¥102.9m | CN¥111.1m | CN¥63.7m | CN¥78.6m | CN¥78.9m | — | — |
| Shareholders' equity | CN¥24.45bn | CN¥24.45bn | CN¥21.25bn | CN¥21.25bn | CN¥12.70bn | CN¥11.89bn | — | CN¥10.60bn |
Financial ratios
Data as of 8 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross margin | 31.2% | 32.5% | 29.5% | 28.3% | 31.3% |
| Operating margin | 21.8% | 22.7% | 20.2% | 19.1% | 24.4% |
| Net margin | 17.5% | 17.9% | 15.5% | 14.7% | 18.5% |
| Return on equity | 23.4% | 29.7% | 29.9% | 26.8% | 34.5% |
| Return on assets | 18.6% | 22.4% | 21.5% | 20.1% | 26.1% |
| Free cash flow yield | 8.7% | 9.7% | 7.2% | — | — |
| Revenue growth | 31.7% | 22.3% | 49.6% | 31.2% | — |
| Earnings growth | 29.3% | 41.4% | 57.1% | 4.5% | — |
| Current ratio | 3.83x | 2.63x | 2.45x | 2.80x | 2.97x |
| Debt to equity | 0.00x | 0.00x | 0.03x | 0.03x | 0.01x |
| Equity ratio | 79.4% | 75.6% | 72.0% | 75.0% | 75.7% |
| Interest coverage | 1486.36x | 884.80x | 279.01x | 281.88x | 422.86x |
| R&D as a share of sales | 0.3% | 0.4% | 0.4% | 0.2% | 0.2% |
| Buybacks as a share of market value | -0.7% | 0.0% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 41.8% | — | — |
| Operating income | 48.1% | — | — |
| Net income | 50.1% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 31.7% | 30.8% | — | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | 23.6 |
| Price to sales | 4.1 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.